Literature DB >> 26936035

The value of local normal limits in quantitative Thallium-201 CZT MPI SPECT.

Bastien Gregoire1,2, Géraldine Pina-Jomir3,4, Laurence Bontemps3,4, Marc Janier3,4, Christian Scheiber3,4.   

Abstract

BACKGROUND: Considering the distinctive characteristics of CZT detectors, automatic quantification of ischemia using normal limits included with software package may deliver suboptimal results for CAD detection. The present study aims to evaluate the benefits of creating normal limits specific to a local population and laboratory protocol. METHODS AND
RESULTS: Two groups were selected from patients who had undergone a CZT MPI. Normal limits were generated with the QPS application based on the population with low likelihood of CAD. Using the vendor-supplied and the population-specific normal limits i-TPD and vessel-specific SDS results obtained for patients who had subsequently undergone coronary angiography were compared with coronary angiography data. A weak correlation was observed for low i-TPD (stress TPD minus rest TPD) and SDS values. Both databases gave similar values for the area under the ROC curve concerning i-TPD (0.75 to 0.74) and SDS results (0.72 to 0.75 for the LAD, 0.62 to 0.64 for the LCx, and 0.63 to 0.67 for the RCA). Sensitivity (60%), specificity (78%), and predictive positive (84%) and negative (52%) values were also similar with a diagnostic and prognostic threshold value.
CONCLUSION: The use of a population-specific created database did not influence the diagnostic value of thallium-201 MPI QPS results using a CZT camera.

Entities:  

Keywords:  CZT camera; Myocardial perfusion imaging; SPECT; normal limits; quantification; thallium-201

Mesh:

Substances:

Year:  2016        PMID: 26936035     DOI: 10.1007/s12350-016-0430-6

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  3 in total

1.  Quantitative same-day rest-stress technetium-99m-sestamibi SPECT: definition and validation of stress normal limits and criteria for abnormality.

Authors:  K F Van Train; J Areeda; E V Garcia; C D Cooke; J Maddahi; H Kiat; G Germano; G Silagan; R Folks; D S Berman
Journal:  J Nucl Med       Date:  1993-09       Impact factor: 10.057

2.  Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography.

Authors:  Rory Hachamovitch; Sean W Hayes; John D Friedman; Ishac Cohen; Daniel S Berman
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

3.  The importance of population-specific normal database for quantification of myocardial ischemia: comparison between Japanese 360 and 180-degree databases and a US database.

Authors:  Kenichi Nakajima; Koichi Okuda; Masaya Kawano; Shinro Matsuo; Piotr Slomka; Guido Germano; Seigo Kinuya
Journal:  J Nucl Cardiol       Date:  2009-02-04       Impact factor: 5.952

  3 in total
  4 in total

1.  Improving cardiac SPECT accuracy: Old robustness for a new gold standard.

Authors:  Alessia Gimelli; Riccardo Liga
Journal:  J Nucl Cardiol       Date:  2016-02-17       Impact factor: 5.952

2.  Quantification with normal limits: New cameras and low-dose imaging.

Authors:  Piotr J Slomka; Mathieu Rubeaux; Guido Germano
Journal:  J Nucl Cardiol       Date:  2016-06-14       Impact factor: 5.952

3.  Normal Databases for the Relative Quantification of Myocardial Perfusion.

Authors:  Mathieu Rubeaux; Yuan Xu; Guido Germano; Daniel S Berman; Piotr J Slomka
Journal:  Curr Cardiovasc Imaging Rep       Date:  2016-06-30

4.  Automated SPECT analysis compared with expert visual scoring for the detection of FFR-defined coronary artery disease.

Authors:  R S Driessen; P G Raijmakers; I Danad; W J Stuijfzand; S P Schumacher; J A Leipsic; J K Min; J Knuuti; A A Lammertsma; A C van Rossum; N van Royen; S R Underwood; P Knaapen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-02-22       Impact factor: 9.236

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.